Skip to main content

Healthcare Analytical Testing Services | Size, Share, Demand & Growth Analysis

Healthcare analytical testing services are used by pharmaceutical, biopharmaceutical, and medical device manufacturers for providing support to all stages of the drug development process, from discovery through preclinical & clinical development to commercial manufacture.

The healthcare analytical testing services market is expected to reach USD 5.97 Billion by 2023 from USD 3.09 Billion in 2017, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the market.

The global healthcare analytical testing services market by end user is segmented into pharmaceutical and biopharmaceutical companies, medical device companies and contract research organizations. In 2017, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the market. The large share of this segment can be attributed to the increasing outsourcing of analytical testing services by pharmaceutical and biopharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time required to validate the process and product.

The rising demand for specialized analytical testing services and growth opportunities in emerging APAC countries are expected to provide further growth opportunities for players operating in the healthcare analytical testing services market. However, pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are some of the factors limiting the growth of this market during the forecast period.

Know more in detail analysis of Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, & Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023.

Visit: https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-market-108923833.html 

Comments

Popular posts from this blog

Top 10 Medical Device Technologies Which Booming in 2019

The global top 10 medical device technologies market is expected to reach USD 428.97 Billion by 2020, at a CAGR of 5.5% from 2015 to 2020. Growth in the global top 10 medical device technologies market is mainly driven by factors such as the rising prevalence of chronic diseases and related increase in disability-adjusted life years (DALYs), technological advancements in medical devices, and growing aging population. Moreover, increasing investments from government bodies and private players in healthcare sectors in emerging economies and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and excise tax on medical devices in the U.S. are restraining the growth of the market. The top 10 medical device technologies market studied in this report is mainly segmented by types and region. Based on type, the top 10 medical device technologies market is segmented into in vitro diagnostics (IV

In Situ Hybridization Market Growth Analysis - Global Forecast To 2021

According to the new market research report  " In situ Hybridization Market  by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected to account for the largest share of the global market. This can be attributed to growing clinical and research in cancer by biotechnology and pharmaceutical companies, g

Home Healthcare Market - Global Forecast to 2022 | CAGR of 8.8%

According to the new market research report " Home Healthcare Market  by Product (BP & Heart Rate Monitor, Ovulation Kit, HIV Test, ECG, Nebulizer, Hearing Aids, Pedometer, Cane, Crutches, Wheelchair), Software, Services (Rehabilitation, Pregnancy, Palliative), & Telehealth - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. Don’t miss out on business opportunities in Home Healthcare Market . Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=696 The global home healthcare market is expected to reach USD 364.69 Billion by 2022 from USD 220.67 Billion in 2016, at a CAGR of 8.8%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The objectives of this study are as follows: To define, describe, segment and forecast the